High--throughput screening of FDA--approved drugs identifies novel immunomodulatory agents for immune-mediated skin diseases

被引：0
|
作者：
Ghorbanalipoor, S. [1 ]
Matsumoto, K. [1 ]
Heimberg, L. [1 ]
Krause, M. [1 ]
Veldkamp, W. [2 ]
Magens, M. [1 ]
Zanken, J. [1 ]
Vidarsson, G. [3 ,4 ]
Visser, R. [3 ,4 ]
Kuenzel, S. [5 ]
Recke, A. [6 ,7 ]
Samavedam, U. [1 ]
Gupta, Y. [1 ]
Zillikens, D. [6 ,7 ]
Bieber, K. [1 ]
Ludwig, R. J. [1 ]
机构：
[1] Univ Lubeck, D-23562 Lubeck, Germany
[2] Radboudumc, Univ Clin, Nijmegen, Netherlands
[3] Sanquin Res, Amsterdam, Netherlands
[4] Landsteiner Lab, Amsterdam, Netherlands
[5] Max Planck Inst Evolutionary Biol, Plon, Germany
[6] Univ Lubeck, Dept Dermatol, D-23562 Lubeck, Germany
[7] Ctr Res Inflammat Skin, D-23562 Lubeck, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2023年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P094
引用
收藏
页码：E46 / E46
页数：1
相关论文
共 50 条
  • [41] A Cell-Based Renilla Luminescence Reporter Plasmid Assay for High-Throughput Screening to Identify Novel FDA-Approved Drug Inhibitors of HPV-16 Infection
    Walhart, Tara
    Isaacson-Wechsler, Erin
    Ang, Kean-Hooi
    Arkin, Michelle
    Tugizov, Sharof
    Palefsky, Joel M.
    SLAS DISCOVERY, 2020, 25 (01) : 79 - 86
  • [42] Comment on "Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project". [Response to Letter]
    Spini, Andrea
    L'Abbate, Luca
    Ingrasciotta, Ylenia
    Pellegrini, Giorgia
    Carollo, Massimo
    Ientile, Valentina
    Leoni, Olivia
    Zanforlini, Martina
    Ancona, Domenica
    Stella, Paolo
    Cavazzana, Anna
    Scapin, Angela
    Lopes, Sara
    Belleudi, Valeria
    Trifiro, Gianluca
    CLINICAL EPIDEMIOLOGY, 2024, 16 : 445 - 446
  • [43] Compartment-Specific Bioluminescence Imaging Platform for the Open-Ended Identification of Novel Immunomodulatory Agents and High-Throughput Evaluation of Anti-Tumor Immune Function
    McMillin, Douglas W.
    Delmore, Jake
    Vanneman, Matthew W.
    Schlossman, Robert L.
    Feather, John
    Munshi, Nikhil C.
    Laubach, Jacob P.
    Richardson, Paul G.
    Dranoff, Glenn
    Anderson, Kenneth C.
    Mitsiades, Constantine S.
    BLOOD, 2010, 116 (21) : 202 - 202
  • [44] Screening for Latent Tuberculosis in Children With Immune-Mediated Inflammatory Diseases Treated With Anti-Tumor Necrosis Factor Therapy: Comparison of Tuberculin Skin and T-SPOT Tuberculosis Tests
    Girit, Saniye
    Atabek, Ayse Ayzit
    Senol, Ebru
    Kockar Kizilirmak, Tuba
    Pekcan, Sevgi
    Goktas, Safak
    Oktem, Sedat
    Kasapcopur, Ozgur
    Cokugras, Haluk
    ARCHIVES OF RHEUMATOLOGY, 2020, 35 (01) : 20 - 28
  • [45] JAK of All Trades: Novel Off-Label Use of the Systemic JAK Inhibitor Upadacitinib As An Adjunct to Systemic Biologic Therapy for Various Immune-Mediated Inflammatory Diseases of the Skin
    Abduelmula, Abrahim
    Wong, Lauren
    Stark, Lauren A.
    Colango, Fernejoy
    Castejon, Aizel
    Lake, Rochelle
    Rankin, Brian D.
    Rimke, Alexander
    Prajapati, Vimal H.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB185 - AB185
  • [46] A novel cell-based assay for the high-throughput screening of epithelial-mesenchymal transition inhibitors: Identification of approved and investigational drugs that inhibit epithelial-mesenchymal transition
    Ishikawa, Hiroyuki
    Menju, Toshi
    Toyazaki, Toshiya
    Miyamoto, Hideaki
    Chiba, Naohisa
    Noguchi, Misa
    Tamari, Shigeyuki
    Miyata, Ryo
    Yutaka, Yojiro
    Tanaka, Satona
    Yamada, Yoshito
    Nakajima, Daisuke
    Ohsumi, Akihiro
    Hamaji, Masatsugu
    Okuno, Yukiko
    Date, Hiroshi
    LUNG CANCER, 2023, 175 : 36 - 46
  • [47] The PICLS high-throughput screening method for agents extending cellular longevity identifies 2,5-anhydro-D-mannitol as novel anti-aging compound
    Alfatah, Mohammad
    Eisenhaber, Frank
    GEROSCIENCE, 2023, 45 (01) : 141 - 158
  • [48] The PICLS high-throughput screening method for agents extending cellular longevity identifies 2,5-anhydro-D-mannitol as novel anti-aging compound
    Mohammad Alfatah
    Frank Eisenhaber
    GeroScience, 2023, 45 : 141 - 158
  • [49] Systematic evaluation of 640 FDA drugs for their effect on CD4+Foxp3+ regulatory T cells using a novel cell-based high throughput screening assay
    Mao, Rui
    Xiao, Wei
    Liu, Haitao
    Chen, Bo
    Yi, Bing
    Kraj, Piotr
    She, Jin-Xiong
    BIOCHEMICAL PHARMACOLOGY, 2013, 85 (10) : 1513 - 1524
  • [50] Screening for latent tuberculosis infection prior to biologic therapy in patients with chronic immune-mediated inflammatory diseases (IMID): Interferon-gamma release assay (IGRA) versus tuberculin skin test (TST)
    Sellami, Meriem
    Fazaa, Alia
    Cheikh, Myriam
    Miladi, Saousen
    Ouenniche, Kmar
    Ennaifer, Rym
    Ben Abdelghani, Kaouther
    Laatar, Ahmed
    EGYPTIAN RHEUMATOLOGIST, 2019, 41 (03): : 225 - 230
12345